RARE- Ultragenyx Pharmaceutical Inc.

Name: Ultragenyx Pharmaceutical Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ultragenyx Pharmaceutical Inc. (RARE) has 7 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. RARE is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Huang Dennis Karl	147.8K	$3.83M	-
Other	Pinion John Richard	133.1K	$3.45M	-
CEO	Kakkis Emil D	132.7K	$3.44M	-
CFO	Horn Howard	105.7K	$2.74M	-
VP	Parschauer Karah Herdman	95.7K	$2.48M	-

Activity

Buys and sells only

Transactions

10 filings · page 17

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 21, 2018	Parschauer Karah Herdman77	EVP And General Counsel	Sell	1,226	$82.77	$101,476.02	-8.0%
Jun 15, 2018	Huizenga Theodore Alan65	VP, Controller And Pao	Sale+OE	955	$83.70	$79,933.50	-7.4%
Jun 13, 2018	Huizenga Theodore Alan65	VP, Controller And Pao	Sell	1,338	$76.97	$102,985.86	-11.9%
Jun 7, 2018	Sharp Shalini	CFO &Executive Vice President	Sale+OE	6,700	$80.07	$536,455.60	-11.1%
May 30, 2018	Sharp Shalini	CFO &Executive Vice President	Sale+OE	13,000	$70.17	$912,171.00	-18.5%
May 30, 2018	Fust Matthew K77	Director	Sell	6,319	$72.00	$454,969.26	-41.9%
May 10, 2018	Parschauer Karah Herdman77	EVP And General Counsel	Sell	1,465	$60.00	$87,900.00	-8.4%
Aug 28, 2017	Kakkis Emil D72	President &CEO	Buy	7,500	$52.52	$393,922.32	+0.1%
May 26, 2017	Huizenga Theodore Alan65	VP, Controller And Pao	Sell	480	$57.46	$27,580.80	-4.9%
Mar 9, 2017	Huizenga Theodore Alan65	Controller And Pao	Sell	2,500	$86.34	$215,845.00	-20.5%

← PrevPage 17Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC